tiprankstipranks
Medicskin Holdings Ltd. (HK:8307)
:8307
Hong Kong Market

Medicskin Holdings Ltd. (8307) AI Stock Analysis

0 Followers

Top Page

HK:8307

Medicskin Holdings Ltd.

(8307)

Select Model
Select Model
Select Model
Neutral 58 (OpenAI - 5.2)
Rating:58Neutral
Price Target:
HK$0.15
▼(-12.35% Downside)
Action:ReiteratedDate:01/24/26
The score is held back primarily by weak financial performance (ongoing losses, declining gross margin, and revenue contraction) and a valuation picture clouded by negative earnings. These are partly offset by relatively strong cash-flow resilience and favorable technical momentum with the price trading above major moving averages.
Positive Factors
Operating cash flow strength
Higher operating cash flow provides durable liquidity support independent of accounting profits. Consistent cash generation funds working capital and modest capex, lowers near-term refinancing needs, and gives management flexibility to sustain operations and execute strategic initiatives over coming months.
Negative Factors
High financial leverage
Extremely high leverage sharply limits financial flexibility and raises interest and refinancing risks. With a thin equity base, the company is more exposed to earnings shortfalls or rate changes, reducing ability to invest or absorb shocks and making balance sheet repair a medium-term priority.
Read all positive and negative factors
Positive Factors
Negative Factors
Operating cash flow strength
Higher operating cash flow provides durable liquidity support independent of accounting profits. Consistent cash generation funds working capital and modest capex, lowers near-term refinancing needs, and gives management flexibility to sustain operations and execute strategic initiatives over coming months.
Read all positive factors

Medicskin Holdings Ltd. (8307) vs. iShares MSCI Hong Kong ETF (EWH)

Medicskin Holdings Ltd. Business Overview & Revenue Model

Company Description
Medicskin Holdings Ltd. (8307) is a leading healthcare company specializing in advanced dermatological and aesthetic solutions. The company operates in the medical and cosmetic sectors, offering a range of products and services designed to enhance...
How the Company Makes Money
null...

Medicskin Holdings Ltd. Financial Statement Overview

Summary
Mixed fundamentals: persistent negative net profit margins and a sharp gross margin decline (80.2% in 2022 to 50.7% in 2025) weigh on results, alongside revenue down 8.2% (2024–2025). Offsetting this, cash flow is relatively resilient with higher operating cash flow (HKD 9.13M in 2025) and strong cash conversion despite net losses.
Income Statement
60
Neutral
Balance Sheet
45
Neutral
Cash Flow
70
Positive
BreakdownTTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income Statement
Total Revenue57.27M45.11M49.88M45.54M49.15M41.71M
Gross Profit18.77M22.87M39.39M36.68M42.14M34.40M
EBITDA6.76M6.29M6.78M6.40M14.55M11.62M
Net Income-1.98M-3.38M-3.05M-3.54M3.92M953.00K
Balance Sheet
Total Assets50.00M57.44M40.06M46.37M56.67M58.84M
Cash, Cash Equivalents and Short-Term Investments25.16M17.34M6.93M6.37M15.47M30.33M
Total Debt19.89M22.79M5.76M11.93M18.67M6.42M
Total Liabilities45.77M53.25M32.48M35.21M42.49M38.85M
Stockholders Equity4.23M4.20M10.95M14.47M17.43M23.45M
Cash Flow
Free Cash Flow9.44M8.29M9.12M946.00K2.33M6.84M
Operating Cash Flow11.42M9.13M10.52M3.25M4.29M9.15M
Investing Cash Flow-2.84M-191.00K-1.40M-5.67M-1.82M-1.65M
Financing Cash Flow-8.26M1.48M-7.21M-6.74M-17.94M-21.03M

Medicskin Holdings Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.17
Price Trends
50DMA
0.17
Negative
100DMA
0.17
Negative
200DMA
0.17
Negative
Market Momentum
MACD
>-0.01
Positive
RSI
35.99
Neutral
STOCH
37.40
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8307, the sentiment is Negative. The current price of 0.17 is above the 20-day moving average (MA) of 0.16, below the 50-day MA of 0.17, and below the 200-day MA of 0.17, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 35.99 is Neutral, neither overbought nor oversold. The STOCH value of 37.40 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8307.

Medicskin Holdings Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
58
Neutral
HK$56.73M362.73-19.93%-2.91%55.41%
53
Neutral
HK$22.46M-197.60138.68%-20.81%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
HK$84.68M-2.11-64.49%-20.66%-77.84%
43
Neutral
HK$84.86M-4.87-27.01%-11.68%-71.01%
42
Neutral
HK$124.00M-20.58-573.79%-30.45%-734.38%
41
Neutral
HK$16.65M-2.2926.12%14.64%-81.95%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8307
Medicskin Holdings Ltd.
0.14
>-0.01
-4.67%
HK:8143
Good Fellow Healthcare Holdings Limited
0.11
0.06
100.00%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.15
0.04
31.03%
HK:8161
MediNet Group Ltd.
0.54
0.20
58.82%
HK:8357
Republic Healthcare Limited
0.14
0.07
91.55%
HK:8437
RMH Holdings Limited
0.25
0.08
47.06%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 24, 2026